Reduction in surgical blood loss and surgery time:

Reduction in surgical blood loss and surgery time: 55% less blood loss compared to control group. These are non-thrombocytopenic subjects: they have normal platelet counts and therefore, cannot be transfused with donor platelets under present transfusion guidelines. But they have benefited from our product.